1. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments
   YU-XIN LIAO et al, 2015 CrossRef
2. Mesenchymal stroma: Role in osteosarcoma progression.
   Margherita Cortini et al, 2017, Cancer Lett CrossRef
3. Culture medium of bone marrow-derived human mesenchymal stem cells effects lymphatic endothelial cells and tumor lymph vessel formation
   JIE ZHAN et al, 2015 CrossRef
4. Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival
   YAO LU et al, 2015 CrossRef
5. Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells
   Ying-Mei Tang et al, 2016 CrossRef
6. Melittin inhibits tumor angiogenesis modulated by endothelial progenitor cells associated with the SDF-1α/CXCR4 signaling pathway in a UMR-106 osteosarcoma xenograft mouse model
   GANG QIN et al, 2016 CrossRef
7. Homologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106
   PENG ZHANG et al, 2014 CrossRef
8. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.
   Ying Zheng et al, 2018, Stem Cell Res Ther CrossRef
9. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells
   Alessandra Pelagalli et al, 2016, IJMS CrossRef
10. Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis
    Nicola Graham et al, 2018, IJMS CrossRef
11. Effects of mesenchymal stem cells on solid tumor metastasis in experimental cancer models: a systematic review and meta-analysis
    Jing-Huan Li et al, 2018, J Transl Med CrossRef
12. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613
    Yong Zhu et al, 2018, Cancer Sci CrossRef
13. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway
    Chun-Hui Zheng et al, 2018, Cell Biol Int CrossRef
14. The Complexity of HIV Persistence and Pathogenesis in the Lung Under Antiretroviral Therapy: Challenges Beyond AIDS
    Sharilyn Almodovar, 2014, Viral Immunology CrossRef
15. Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
    Erik De Clercq, 2019, Antivir Chem Chemother CrossRef
16. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice
    Alexandros Stamatopoulos et al, 2019, Journal of Bone Oncology CrossRef
17. Adult Stem Cell Functioning in the Tumor Micro-Environment.
    Yuhan Jiang et al, 2019, Int J Mol Sci CrossRef
18. MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN
    Yao-Qi Yang et al, 2014, Tumor Biol. CrossRef
19. CXCR4 Receptor Overexpression in Mesenchymal Stem Cells Facilitates Treatment of Acute Lung Injury in Rats
    Jing-Xian Yang et al, 2015, J. Biol. Chem. CrossRef
20. Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model?
    Megan E. Aanstoos et al, 2016, Clin Orthop Relat Res CrossRef
21. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion
    Raffaela Fontanella et al, 2016, Cancer Letters CrossRef
22. Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status
    Pierre Avril et al, 2016, Journal of Bone Oncology CrossRef
23. Tectorigenin inhibits osteosarcoma cell migration through downregulation of matrix metalloproteinases in vitro.
    Yu Guo et al, 0 CrossRef
24. Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model
    Woong Chol Kang et al, 2016, Korean J Physiol Pharmacol CrossRef
25. Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells
    Xin Zhang et al, 2017, Oncol Lett CrossRef
26. Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy.
    Francesca Cersosimo et al, 2020, Int J Mol Sci CrossRef
27. Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway
    Xuhui Ge et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
28. SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack
    Nicholas Evans et al, 2021, HIV CrossRef
29. The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response
    Caterina Cascini et al, 2021, Cells CrossRef
30. Transition between canonical to non-canonical Wnt signaling during interactions between mesenchymal stem cells and osteosarcomas
    Asulin Masha et al, 2020, Open J Orthop Rheumatol CrossRef
31. Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy
    Virinder Kaur Sarhadi et al, 2021, IJMS CrossRef
32. To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
    Chunfeng Xu et al, 2021, Front. Cell Dev. Biol. CrossRef
33. MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells
    Ming Liu et al, 2016, oncol res CrossRef
34. Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications
    Carla Vicinanza et al, 2022, WJSC CrossRef
35. Stem Cell-Induced Cell Motility: A Removable Obstacle on the Way to Safe Therapies?
    Margit Rosner et al, 2022 CrossRef
36. Osteogenesis in the presence of chemotherapy: A biomimetic approach
    Ava A Brozovich et al, 2022, J Tissue Eng CrossRef
37. Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis
    Jiamin Jin et al, 2023, International Immunopharmacology CrossRef